Literature DB >> 16477644

Inhibins are the major activin ligands expressed during early thymocyte development.

Paula Licona1, Jesús Chimal-Monroy, Gloria Soldevila.   

Abstract

Activins are members of the transforming growth factor-beta (TGFbeta) superfamily, which regulate cell differentiation processes. Here we report the first quantitative analysis of the expression of Activin/Inhibin ligands, type I and II receptors, as well as Smad proteins in fetal (E14-E16) and adult thymic subpopulations. Our data showed that Alk4, ActRIIA, ActRIIB, and Smads 2, 3, and 4, are expressed in fetal thymus (E14 > E15 > E16) and in thymocytes from adult mice (mostly in the double negative [DN] subpopulation). Ligand expression analysis showed that betaA, betaB, and alpha subunits were mainly detected in thymic stromal cells. Interestingly, alpha subunits were expressed at much higher levels compared to betaA and betaB subunits, demonstrating for the first time the potential role of Inhibins as important mediators during early T cell development. Our data indicate that Activin/Inhibin signaling could regulate the process of thymus organogenesis and early thymocyte differentiation, as it has been demonstrated for other members of the TGF-beta superfamily. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477644     DOI: 10.1002/dvdy.20707

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  9 in total

1.  Maintenance of a normal thymic microenvironment and T-cell homeostasis require Smad4-mediated signaling in thymic epithelial cells.

Authors:  Lukas T Jeker; Thomas Barthlott; Marcel P Keller; Saulius Zuklys; Mathias Hauri-Hohl; Chu-Xia Deng; Georg A Holländer
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

Review 2.  Immunoregulation by members of the TGFβ superfamily.

Authors:  WanJun Chen; Peter Ten Dijke
Journal:  Nat Rev Immunol       Date:  2016-11-25       Impact factor: 53.106

3.  Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.

Authors:  Brian C Goh; Vandana Singhal; Angelica J Herrera; Ryan E Tomlinson; Soohyun Kim; Marie-Claude Faugere; Emily L Germain-Lee; Thomas L Clemens; Se-Jin Lee; Douglas J DiGirolamo
Journal:  J Biol Chem       Date:  2017-06-28       Impact factor: 5.157

4.  Activins and inhibins: novel regulators of thymocyte development.

Authors:  Paula Licona-Limón; German Alemán-Muench; Jesus Chimal-Monroy; Marina Macías-Silva; Eduardo A García-Zepeda; Martin M Matzuk; Teresa I Fortoul; Gloria Soldevila
Journal:  Biochem Biophys Res Commun       Date:  2009-02-13       Impact factor: 3.575

5.  CD8 T-cell Recruitment Into the Central Nervous System of Cuprizone-Fed Mice: Relevance to Modeling the Etiology of Multiple Sclerosis.

Authors:  Mohammed S M Almuslehi; Monokesh K Sen; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Front Cell Neurosci       Date:  2020-03-10       Impact factor: 5.505

6.  Inhibins tune the thymocyte selection process by regulating thymic stromal cell differentiation.

Authors:  Ebzadrel Carbajal-Franco; Marisol de la Fuente-Granada; Germán R Alemán-Muench; Eduardo A García-Zepeda; Gloria Soldevila
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

7.  A Key Role for Inhibins in Dendritic Cell Maturation and Function.

Authors:  Roxana Olguín-Alor; Marisol de la Fuente-Granada; Laura C Bonifaz; Laura Antonio-Herrera; Eduardo A García-Zepeda; Gloria Soldevila
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

8.  Betaglycan (TβRIII) is expressed in the thymus and regulates T cell development by protecting thymocytes from apoptosis.

Authors:  German R Aleman-Muench; Valentin Mendoza; Kaye Stenvers; Eduardo A Garcia-Zepeda; Fernando Lopez-Casillas; Chander Raman; Gloria Soldevila
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

Review 9.  A Tale from TGF-β Superfamily for Thymus Ontogeny and Function.

Authors:  Arnon Dias Jurberg; Larissa Vasconcelos-Fontes; Vinícius Cotta-de-Almeida
Journal:  Front Immunol       Date:  2015-09-10       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.